V

Valneva
VLA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€525.85M
EV
€573.89M
Shares Outstanding
168.08M
Beta
1.29

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€6.56
P/E 2025E
-
P/Revenue 2025E
2.72x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Valneva SE

gainify

V

Valneva SE

VLA

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunizati...

Sector

Healthcare

Industry

Biotechnology

CEO

Lingelbach, Thomas

Employees

713

IPO Date

2007-06-29

Headquarters

6 rue Alain Bombard, Saint-Herblain, Pays de la Loire, 44800, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved